BeneFIX

In the US, BeneFIX (coagulation factor ix systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Factor IX Deficiency and Hemophilia B.

US matches:

• BeneFix

UK matches:

• BeneFIX (Baxter Healthcare ) (SPC)
• BeneFIX (Wyeth Pharmaceuticals) (SPC)

Ingredient matches for BeneFIX

Coagulation Factor IX, Human, recombinant

Coagulation Factor IX, Human, recombinant Nonacog Alfa (a derivative of Coagulation Factor IX, Human, recombinant) is reported as an ingredient of BeneFIX in the following countries:

• Australia


• Austria


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• Ireland


• Italy


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Spain


• Sweden


• Switzerland


• Taiwan


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.